ET Receptor Antagonist 2 (Compound 16j) is an orally active ET receptor antagonist with an IC50 of 0.22 nM, suitable for pulmonary arterial hypertension (PAH) research. It has been shown to mitigate monocrotaline-induced PAH in a rat model [1].
Molecular Weight:
471.53
Formula:
C22H25N5O5S
* VAT and and shipping costs not included. Errors and price changes excepted
